Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Breast Neoplasms

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amorosi, CJ; Dunham, MJ; Fowler, DM; Gallis, B; Kowalski, JP; McDonald, MG; Nath, A; Paco, L; Ray, S; Rettie, AE; Sitko, KA; Totah, RA1
Achyut, BR; Angara, K; Arbab, AS; Borin, TF; Rashid, MH1

Reviews

1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Breast Neoplasms

ArticleYear
Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.
    International journal of molecular sciences, 2017, Dec-08, Volume: 18, Issue:12

    Topics: Arachidonic Acid; Breast Neoplasms; Cytochrome P450 Family 4; Female; Humans; Hydroxyeicosatetraenoic Acids; Molecular Targeted Therapy; Neoplasm Metastasis; Signal Transduction; Tumor Microenvironment

2017

Other Studies

1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Breast Neoplasms

ArticleYear
Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in
    Drug metabolism and disposition: the biological fate of chemicals, 2017, Volume: 45, Issue:12

    Topics: Amidines; Breast Neoplasms; Cytochrome P450 Family 4; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Interleukin-1 Receptor-Associated Kinases; Lauric Acids; Mass Spectrometry; Microsomes, Liver; Molecular Docking Simulation; Oxidation-Reduction; Recombinant Proteins; Saccharomyces cerevisiae

2017